Company / Revenue
AYTU BIOPHARMA, INC Revenue History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$66.4M
FY2025
5-year range
$65.2M / $107.4M
FY2021-FY2025
Trend
+1.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $107M to $66M over the past 2 years.
Based on SEC 10-K filings.
$66M in FY2025 with a 10-year CAGR of +73.9%.
Declined from $107M to $66M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -11.8%
- 5-Year CAGR
- +19.2%
- 10-Year CAGR
- +73.9%
Key checks
Key Insights
- 5-year CAGR of +19.2%, indicating consistent growth.
- In FY2025, revenue increased 1.8% year-over-year.
- Peak revenue was recorded in FY2023.
- Lowest revenue in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $66.4M | +1.8% |
| FY2024 | $65.2M | -39.3% |
| FY2023 | $107.4M | +11.1% |
| FY2022 | $96.7M | +47.3% |
| FY2021 | $65.6M | +137.5% |
| FY2020 | $27.6M | +655.0% |
| FY2018 | $3.7M | +13.6% |
| FY2017 | $3.2M | +25.7% |
| FY2016 | $2.6M | +878.8% |
| FY2015 | $261.8K | +4886.3% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026